Healthways, Inc. (TVTY)
(Delayed Data from NSDQ)
$22.85 USD
+0.75 (3.39%)
Updated May 3, 2019 04:00 PM ET
After-Market: $22.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.85 USD
+0.75 (3.39%)
Updated May 3, 2019 04:00 PM ET
After-Market: $22.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Tivity Health (TVTY) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Tivity Health (TVTY) delivered earnings and revenue surprises of -4.76% and 4.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of -80% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
NovoCure (NVCR) delivered earnings and revenue surprises of 76.47% and 1.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Is Tivity Health (TVTY) a Suitable Stock for Value Investors?
by Zacks Equity Research
Let's see if Tivity Health, Inc. (TVTY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Tivity Health (TVTY) Lags Q4 Earnings Estimates
by Zacks Equity Research
Tivity Health (TVTY) delivered earnings and revenue surprises of -21.05% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Q4 Earnings Meet Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0% and 0.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Tivity Health (TVTY) Q4 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are These Medical Stocks a Great Value Stocks Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tivity Health (TVTY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Tivity Health (TVTY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Should Value Investors Buy These Medical Stocks?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TVTY or DOCS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TVTY vs. DOCS: Which Stock Is the Better Value Option?
Tivity Health (TVTY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tivity Health (TVTY) delivered earnings and revenue surprises of 16.67% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Tivity Health (TVTY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tivity Health (TVTY) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tivity Health (TVTY) delivered earnings and revenue surprises of 37.14% and 6.89%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
6 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Icon PLC (ICLR) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Analysts Estimate Tivity Health (TVTY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avantor, Inc. (AVTR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: Home Depot, Tivity Health, Landstar System and Union Pacific
by Zacks Equity Research
Zacks.com featured highlights include: Home Depot, Tivity Health, Landstar System and Union Pacific
Add These 4 GARP Stocks to Your Portfolio for Maximum Returns
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Avantor, Inc. (AVTR) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tivity Health (TVTY) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Tivity Health (TVTY) delivered earnings and revenue surprises of 37.93% and 9.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Tivity Health (TVTY) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Tivity Health (TVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: iRobot, Microsoft, Apple, NVIDIA and Tivity Health